EPITOPE SUMMARY | |
---|---|
1-hexadecanoyl-2-(9Z-octadecenoyl)-sn-glycero-3-phospho-D-myo-inositol (epitope ID ) has this structure: . The epitope has these synonyms: (2R)-1-(hexadecanoyloxy)-3-[(hydroxy{[(1S,2R,3R,4S,5S,6R)-2,3,4,5,6-pentahydroxycyclohexyl]oxy}phosphoryl)oxy]propan-2-yl (9Z)-octadec-9-enoate, 1-16:0-2-18:1-phosphatidylinositol, 1-hexadecanoyl-2-(9Z-octadecenoyl)-sn-glycero-3-phospho-(1'-myo-inositol), 1-Palmitoyl-2-oleoyl-sn-glycero-3-phosphoinositol, 16:0-18:1-PI, 2-oleoyl-1-palmitoyl-sn-glycero-3-phospho-D-myo-inositol, Phosphatidylinositol(16:0/18:1), Phosphatidylinositol(16:0/18:1omega9), Phosphatidylinositol(34:1), PI(16:0/18:1(9Z)), PI(16:0/18:1), PI(16:0/18:1omega9), PI(34:1), PIno(16:0/18:1), PIno(16:0/18:1omega9), PIno(34:1). This epitope has been studied for immune reactivity in publication(s), tested in T cell assays, MHC ligand assays and has 3D structure(s) and . |
CURATED EXPERIMENTAL DATA | |
---|---|
MHC Ligand Assay(s) | |
MHC molecule | Positive / All |
human CD1b | / |
mouse CD1d | / |
T Cell Assay(s) | |
Assay Type | Positive / All |
dissociation constant KD | / |
3D structure | / |
IFNg release | / |
EXTERNAL RESOURCES | |
---|---|
Resource | Link |